Prevalence of anti-thrombospondin type-1 domain-containing 7A antibodies in Japanese patients with membranous nephropathy

Prevalence of anti-thrombospondin type-1 domain-containing 7A antibodies in Japanese patients with membranous nephropathy - Prevalence of anti-thrombospondin type-1 domain-containing 7A antibodies-related membranous nephropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018079

Enrollment

100

Registered

2015-06-25

Start date

2015-03-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Membranous nephropathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with the histologic diagnosis of MN established in our institution from 1980 to the present date

Exclusion criteria

Exclusion criteria: Patients without clinical information or renal specimen

Design outcomes

Primary

Measure	Time frame
The prevalence of enhanced granular expression of thrombospondin type-1 domain-containing7A and phospholipase A2 receptor in glomeruli of Japanese patients with idiopathic membranous nephropathy.	—

Secondary

Measure	Time frame
Clinical characteristics of patients with enhanced granular expression of thrombospondin type-1 domain-containing7A and phospholipase A2 receptor in glomeruli. The prevalence of enhanced granular expression of IgG4 in glomeruli of Japanese patients with idiopathic membranous nephropathy.	—

Countries

Japan

Contacts

Public ContactTakamasa Iwakura

Hamamatsu University School of Medicine Internal Medicine I

tkms0421@hama-med.ac.jp053-435-2261

Outcome results